BEAT - BioTelemetry, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
430,676
399,472
286,776
208,332
178,513
Cost of Revenue
162,373
148,986
114,406
78,882
71,956
Gross Profit
268,303
250,486
172,370
129,450
106,557
Operating Expenses
Research Development
13,281
11,206
11,101
8,355
7,111
Selling General and Administrative
163,917
152,585
118,305
84,513
75,818
Total Operating Expenses
175,405
163,791
129,406
92,868
82,929
Operating Income or Loss
92,898
86,695
42,964
36,582
23,628
Interest Expense
9,805
9,429
4,897
-
-
Total Other Income/Expenses Net
-35,677
-35,762
-48,463
-18,570
-14,110
Income Before Tax
47,416
41,504
-10,396
15,770
7,896
Income Tax Expense
8,755
-370
6,747
-37,667
468
Income from Continuing Operations
38,661
41,874
-17,143
53,437
7,428
Net Income
38,661
42,820
-15,956
53,437
7,428
Net Income available to common shareholders
38,661
42,820
-15,956
53,437
7,428
Reported EPS
Basic
-
1.31
-0.53
1.91
0.27
Diluted
-
1.20
-0.53
1.75
0.26
Weighted average shares outstanding
Basic
-
32,709
30,386
27,920
27,116
Diluted
-
35,783
30,386
30,489
29,089
EBITDA
-
91,101
23,062
50,851
36,116